Redditch, United Kingdom

Charmaine Paulina Quarterman

This inventor holds 1 USPTO granted patent. Top assignee: Cobra Therapeutics Limited. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charmaine Paulina Quarterman. Retrieved from https://idiyas.com/inventor/charmaine-paulina-quarterman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Charmaine Paulina Quarterman: Innovator in Pharmaceutical Prodrugs

Introduction

Charmaine Paulina Quarterman is a notable inventor based in Redditch, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that enhance drug solubility and efficacy.

Latest Patents

Charmaine holds 1 patent for her work on "Analogues or derivatives of quercetin (prodrugs)." This patent focuses on novel carbamate ester analogues or derivatives of quercetin, which are designed to have enhanced aqueous solubility. These compounds are especially suitable for use as biodegradable prodrugs in pharmaceutical compositions formulated for clinical use.

Career Highlights

Charmaine is currently associated with Cobra Therapeutics Limited, where she applies her expertise in pharmaceutical innovation. Her work is pivotal in advancing drug formulations that can lead to improved therapeutic outcomes.

Collaborations

Throughout her career, Charmaine has collaborated with esteemed colleagues such as Bernard Thomas Golding and Roger John Griffin. These partnerships have contributed to her success in the field of pharmaceutical research and development.

Conclusion

Charmaine Paulina Quarterman exemplifies the spirit of innovation in the pharmaceutical industry through her groundbreaking work on prodrugs. Her contributions are paving the way for more effective and biodegradable drug formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…